Cell-penetrating γ-peptide/antimicrobial undecapeptide conjugates with anticancer activity

被引:14
|
作者
Roses, Cristina [5 ]
Carbajo, Daniel [4 ]
Sanclimens, Gloria [4 ]
Farrera-Sinfreu, Josep [4 ]
Blancafort, Adriana [1 ]
Oliveras, Gloria [1 ]
Cirac, Anna D. [5 ]
Bardaji, Eduard [5 ]
Puig, Teresa [1 ]
Planas, Marta [5 ]
Feliu, Lidia [5 ]
Albericio, Fernando [2 ,3 ]
Royo, Miriam [4 ]
机构
[1] Univ Girona, Sch Med, Girona Biomed Res Inst IDIBGi, Girona 17071, Spain
[2] Barcelona Sci Pk, Inst Res Biomed, Barcelona 08028, Spain
[3] Univ Barcelona, Dept Organ Chem, E-08028 Barcelona, Spain
[4] Barcelona Sci Pk, Combinatorial Chem Unit, Barcelona 08028, Spain
[5] Univ Girona, LIPPSO, Dept Quim, Girona 17071, Spain
关键词
gamma-Peptides; Anticancer; Antimicrobial peptides; Cell-penetrating peptides; Foldamers; HOST-DEFENSE PEPTIDES; CATIONIC ANTIMICROBIAL PEPTIDES; DE-NOVO DESIGN; BETA-PEPTIDES; FOLDAMERS; MECHANISM; DELIVERY; MOLECULES; PEPTOIDS; BIOLOGY;
D O I
10.1016/j.tet.2012.02.003
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
In this study, we combined a cell-penetrating gamma-peptide, PEG-1, with antimicrobial undecapeptides in order to provide compounds with anticancer properties against MDA-MB-231 human breast cancer cells. We demonstrated that the conjugates were more cytotoxic than Ac-PEG-1 and the parent undecapeptides. We also evaluated the toxicity of the conjugates against non-malignant cells. The peptide conjugate with the best biological profile was BP77-PEG-1, which, at 10 mu M, showed a 71% growth inhibition in MDA-MB-231 cells and only a 17% inhibition in non-malignant cells. Therefore, this study suggests that PEG-1 mediated the undecapeptide delivery into cancer cells and that these conjugates are the proof-of-concept of this strategy to generate improved anticancer drugs based on peptides. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4406 / 4412
页数:7
相关论文
共 50 条
  • [41] The Effect of Conjugation with Octaarginine, a Cell-Penetrating Peptide on Antifungal Activity of Imidazoacridinone Derivative
    Rzad, Kamila
    Paluszkiewicz, Ewa
    Neubauer, Damian
    Olszewski, Mateusz
    Kozlowska-Tylingo, Katarzyna
    Kamysz, Wojciech
    Gabriel, Iwona
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [42] Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer
    Duan, Ziqing
    Chen, Cuitian
    Qin, Jing
    Liu, Qi
    Wang, Qi
    Xu, Xinchun
    Wang, Jianxin
    DRUG DELIVERY, 2017, 24 (01) : 752 - 764
  • [43] Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections
    Buccini, Danieli F.
    Cardoso, Marlon H.
    Franco, Octavio L.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 10
  • [44] Complexation of Cell-Penetrating Peptide-Polymer Conjugates with Polyanions Controls Cells Uptake of HPMA Copolymers and Anti-tumor Activity
    Shamay, Yosi
    Shpirt, Lina
    Ashkenasy, Gonen
    David, Ayelet
    PHARMACEUTICAL RESEARCH, 2014, 31 (03) : 768 - 779
  • [45] Polypharmacological Cell-Penetrating Peptides from Venomous Marine Animals Based on Immunomodulating, Antimicrobial, and Anticancer Properties
    Hemmati, Shiva
    Kazerooni, Haniyeh Rasekhi
    MARINE DRUGS, 2022, 20 (12)
  • [46] Conjugation with Cationic Cell-Penetrating Peptide Increases Pulmonary Absorption of Insulin
    Patel, Eena N.
    Wang, Jeffrey
    Kim, Kwang-Jin
    Borok, Zea
    Crandall, Edward D.
    Shen, Wei-Chiang
    MOLECULAR PHARMACEUTICS, 2009, 6 (02) : 492 - 503
  • [47] Novel Peptide-Drug Conjugates with Dual Anticancer Activity
    O'Flaherty, Siobhan
    Luzina, Olga A.
    Dyrkheeva, Nadezhda S.
    Krier, Ysaline
    Leprince, Jerome
    Zakharenko, Alexandra L.
    Pokrovsky, Mikhail A.
    Pokrovsky, Andrey G.
    Lavrik, Olga I.
    Salakhutdinov, Nariman F.
    Varbanov, Mihayl
    Devocelle, Marc
    Volcho, Konstantin P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [48] Cell-penetrating peptides improve pharmacokinetics and pharmacodynamics of anticancer drugs
    Rusiecka, Izabela
    Gagalo, Iwona
    Kocic, Ivan
    TISSUE BARRIERS, 2022, 10 (01):
  • [49] Fluorescent Leakage Assay to Investigate Membrane Destabilization by Cell-Penetrating Peptide
    Konate, Karidia
    Seisel, Quentin
    Vives, Eric
    Boisguerin, Prisca
    Deshayes, Sebastien
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (166):
  • [50] Oral biodrug delivery using cell-penetrating peptide
    Khafagy, El-Sayed
    Morishita, Mariko
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (06) : 531 - 539